T1	intervention 69 78	tamoxifen
T2	control 83 93	exemestane
T3	eligibility 97 142	postmenopausal women with early breast cancer
T4	eligibility 581 633	Postmenopausal patients with ER+ early breast cancer
T5	outcome-Measure 813 839	endometrial thickness (ET)
T6	outcome-Measure 844 863	uterine volume (UV)
T7	No-of-participants 876 879	123
T8	intervention-participants 920 922	61
T9	control-participants 943 945	62
T10	outcome 1031 1052	ET at 6 and 12 months
T11	intervention-value 1108 1113	66.1%
T12	intervention-value 1118 1123	64.3%
T13	control-value 1131 1136	12.1%
T14	control-value 1141 1145	6.8%
T15	outcome 1174 1188	Mean ET and UV
